Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL providing for duty-free treatment for specified pharmaceutical active ingredients bearing an "international non-proprietary name" (INN) from the World Health Organisation and specified products used for the manufacture of finished pharmaceuticals and amending Annex I to Regulation (EEC) No 2658/87 
Date: 2010-07-27
Institutions: European Commission
Subjects: CCT duties, common commercial policy, import policy, pharmaceutical product, tariff exemption

EN 

EN 

   EN 

 
 
EUROPEAN COMMISSION 

Brussels, 27.7.2010 
COM(2010)397 final 

2010/0214 (COD) 

Proposal for a 

REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL 

providing for duty-free treatment for specified pharmaceutical active ingredients 
bearing an "international non-proprietary name" (INN) from the World Health 
Organisation and specified products used for the manufacture of finished 
pharmaceuticals and amending Annex I to Regulation (EEC) No 2658/87 

EN 

   EN 

 
 
 
  
EXPLANATORY MEMORANDUM 

The  Record  of  Discussions  of  the  Trade  in  Pharmaceutical  Products  is  an  arrangement 
between the most important pharmaceutical producing countries to reduce to zero and on an 
MFN basis their WTO bindings of duties on certain pharmaceutical products, including active 
ingredients and intermediates. The Parties to the Agreement are the EU, US, Japan, Canada, 
Switzerland, Norway and Macao (China).  

The  arrangement  originally  covered  over  six  thousand  products.  However,  given  that  new 
pharmaceutical products are constantly being developed, the arrangement envisages periodic 
reviews. The Parties agreed to "meet under the auspices of the Council for Trade in Goods of 
the  WTO,  normally  at  least  once  every  three  years,  to  review  the  product  coverage  with  a 
view  to  including,  by  consensus,  additional  pharmaceutical  products  for  tariff  elimination." 
The coverage was first reviewed in 1995-1996 and as a result an extra 465 products received 
duty  free  treatment.  The  second  review  in  1998  (implemented  in  July  1999)  resulted  in  an 
extra  639  products  receiving  duty  free  treatment.  The  third  review  in  2006  resulted  in  the 
addition of 1290 products.  

This  proposal  invites  Council  and  Parliament  to  authorise  the  addition  of  a  further  718 
pharmaceutical and chemical products to the already-existing list of 8619 products benefiting 
from bound duty-free treatment upon importation into the EU.  

A fourth review of the products covered by the Record was launched in 2009, in accordance 
with Article 3 of the Record, which requires Participants to review at least once every three 
years  the  product  coverage  with  a  view  to  including  additional  pharmaceutical  products  for 
tariff  elimination.  The  EU  participated  in  these  technical  discussions.  In  the  course  of  these 
discussions,  Participants  concluded  that  additional  INNs  and  pharmaceutical  intermediates 
used for production and manufacture of finished pharmaceuticals should be granted duty-free 
treatment  and  that  the  list  of  specified  prefixes  and  suffixes  for  salts,  esters  or  hydrates  of 
INNs should be expanded, thereby adding 718 new substances to the list of products eligible 
for duty-free treatment. 

The Member States have been consulted during the technical discussions. 

The Council and Parliament are invited to adopt the attached proposal for a Regulation of the 
European Parliament and of the Council amending Annex I to Council Regulation (EEC) No 
2658/87 in order to extend duty-free treatment in the European Union to the above-mentioned 
pharmaceutical and chemical products. 

EN 

2 

   EN 

 
2010/0214 (COD) 

Proposal for a 

REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL 

providing for duty-free treatment for specified pharmaceutical active ingredients 
bearing an "international non-proprietary name" (INN) from the World Health 
Organisation and specified products used for the manufacture of finished 
pharmaceuticals and amending Annex I to Regulation (EEC) No 2658/87 

THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION, 

Having  regard  to  the  Treaty  on  the  Functioning  of  the  European  Union,  and  in  particular 
Article 207 thereof, 

Having regard to the proposal from the European Commission, 

After transmission of the draft legislative act to the national Parliaments, 

Acting in accordance with the ordinary legislative procedure, 

Whereas: 

(1) 

(2) 

(3) 

(4) 

In  the  course  of  the  Uruguay  Round  negotiations,  the  Community  and  a  number  of 
countries agreed that duty-free treatment should be granted to pharmaceutical products 
falling within the Harmonised System (HS) Chapter 30 and HS headings 2936, 2937, 
2939 and 2941 as well as to designated pharmaceutical active ingredients bearing an 
“international  non-proprietary  name”  (INN)  from  the  World  Health  Organisation, 
specified  salts,  esters  and  hydrates  of  such  INNs,  and  designated  pharmaceutical 
intermediates used for the production and manufacture of finished pharmaceuticals. 

The  results  of  the  discussions,  as  set  out  in  the  record  of  discussions,  were 
incorporated  into  the  tariff  schedules  of  the  participants  annexed  to  the  Marrakesh 
Protocol to GATT 1994. 

Participants concluded that representatives of the WTO members, party to the record 
of  discussions,  would  meet  under  the  auspices  of  the  Council  for  Trade  in  Goods  of 
the WTO, normally at least once every three years to review the product coverage with 
a  view  to  including,  by  consensus,  additional  pharmaceutical  products  for  tariff 
elimination. 

Three such reviews have taken place with the result that a certain number of additional 
INNs  and  pharmaceutical  intermediates  used  for  the  production  and  manufacture  of 
finished pharmaceuticals have been granted duty-free treatment, that certain  of those 
intermediates  have  been  transferred  to  the  list  of  INNs,  and  that  the  list  of  specified 
prefixes and suffixes for salts, esters or hydrates of INNs has been expanded. 

EN 

3 

   EN 

 
(5) 

(6) 

A fourth review was deemed appropriate and was launched in 2009. It concluded that 
a  certain  number  of  additional  INNs  and  pharmaceutical  intermediates  used  for  the 
production  and  manufacture  of  finished  pharmaceuticals  should  be  granted  duty-free 
treatment, that a certain number of the already included pharmaceutical intermediates 
should  be  transferred  to  the  list  of  INNs,  and  that  the  list  of  specified  prefixes  and 
suffixes for salts, esters or hydrates of INNs should be expanded. 

Council  Regulation  (EEC)  No  2658/87  of  23  July  1987  on  the  tariff  and  statistical 
nomenclature  and  on  the  Common  Customs  Tariff1  established  the  Combined 
Nomenclature (CN) and set out the conventional duty rates of the Common Customs 
Tariff. 

(7) 

Regulation (EEC) No 2658/87 should therefore be amended accordingly. 

(8) 

[In  order  to  ensure  that  the  measures  provided  for  in  this  Regulation  apply  on  1 
January 2011, it should enter into force on the day following that of its publication.] 

HAVE ADOPTED THIS REGULATION: 

As  from  1  January  2011  the  European  Union  shall  extend  duty-free  treatment  to  the  INNs 
listed in Annex I. 

Article 1 

Article 2 

As from 1 January 2011 the list of prefixes and suffixes which, in combination with included 
INNs,  describe  the  salts,  esters  or  hydrates  of  INNs  which  are  also  eligible  for  duty-free 
treatment, on condition that they are classifiable in the same six-digit HS subheading as the 
corresponding INN, shall be amended as set out in Annex II. 

Article 3 

As  from  1  January  2011  the  European  Union  shall  extend  duty-free  treatment  to  the 
pharmaceutical 
the  production  and  manufacture  of  finished 
intermediates  used 
pharmaceuticals, listed in Annex III. 

in 

As  from  1  January  2011  the  pharmaceutical  intermediates  listed  in  Annex  IV  shall  be 
withdrawn from the list of such compounds receiving duty-free treatment. 

Article 4 

1 

OJ L 256, 7.9.1987, p. 1. 

EN 

4 

   EN 

 
                                                 
Article 5 

Annexes 3, 4 and 6 of Section II of Part three of Annex I to Regulation (EEC) No 2658/87, 
(Lists of pharmaceutical substances which qualify for duty-free treatment), shall be amended 
accordingly. 

This  Regulation  shall  enter  into  force  on  the  day  following  that  of  its  publication  in  the 
Official Journal of the European Union. 

Article 6 

This Regulation shall be binding in its entirety and directly applicable in all Member States. 

Done at Brussels, […] 

For the European Parliament 
The President 
[…] 

For the Council 
The President 
[…] 

EN 

5 

   EN 

 
ANNEX I 

List  of  international  non-proprietary  names  (INNs)  to  be  added  to  the  list  of  products 
receiving duty-free treatment included  in Annex 3 to Annex I to Regulation (EEC) No 
2658/87 

CN code 

2842 90 80 
2843 90 90 
2844 40 30 
2904 10 00 
2906 19 00 
2909 30 90 
2916 19 95 
2916 39 00 
2918 19 98 
2919 90 00 
2920 90 85 
2921 19 99 
2922 19 85 
2922 19 85 
2922 29 00 
2922 50 00 
2922 50 00 
2922 50 00 
2923 10 00 
2924 29 98 
2924 29 98 
2924 29 98 
2924 29 98 
2924 29 98 
2924 29 98 
2924 29 98 
2924 29 98 
2924 29 98 
2924 29 98 
2924 29 98 
2924 29 98 
2924 29 98 
2924 29 98 
2925 19 95 
2928 00 90 
2928 00 90 
2928 00 90 
2928 00 90 
2928 00 90  
2929 90 00 
2930 90 99 

Name 

CAS RN 
119175-48-3 fermagate  
759457-82-4 padeliporfin  
123748-56-1 iodofiltic acid (123I)  
21668-77-9 eprodisate  
199798-84-0 elocalcitol  

24150-24-1 terameprocol  
81485-25-8 peretinoin  
51543-40-9 tarenflurbil  
174022-42-5 bevirimat  
258516-89-1 fospropofol  
163133-43-5 naproxcinod  
3687-18-1 tramiprosate  
68392-35-8 afimoxifene  
753449-67-1 ronacaleret  
433265-65-7 faxeladol  
121524-08-1 amibegron  
329773-35-5 cinaciguat  
643094-49-9 fasobegron  
856676-23-8 choline fenofibrate  
847353-30-4 arbaclofen placarbil  
194785-19-8 bedoradrine  
194085-75-1 carisbamate 
254750-02-2 emricasan  
355129-15-6 eprotirome  
402567-16-2 firategrast  
478296-72-9 gabapentin enacarbil  
15866-90-7 incyclinide  
202844-10-8 indantadol  

96847-55-1 levomilnacipran  
608137-32-2 lisdexamfetamine  
652990-07-3 milveterol  
181816-48-8 ombrabulin  
289656-45-7 senicapoc  

19171-19-8 pomalidomide  
22033-87-0 olesoxime  
2675-35-6 sivifene  
816458-31-8 tecovirimat  
238750-77-1 tosedostat  
149647-78-9 vorinostat  

31645-39-3 palifosfamide  
608141-41-9 apremilast  

EN 

6 

   EN 

 
CN code 

2930 90 99 
2930 90 99 
2930 90 99 
2930 90 99 
2930 90 99 
2930 90 99 
2930 90 99 
2930 90 99 
2930 90 99 
2930 90 99 
2930 90 99 
2930 90 99 
2931 00 99 
2932 19 00 
2932 19 00 
2932 29 85 
2932 99 00 
2932 99 00 
2932 99 00 
2932 99 00 
2932 99 00 
2932 99 00 
2932 99 00 
2932 99 00 
2932 99 00 
2933 19 90 
2933 19 90 
2933 19 90 
2933 19 90 
2933 29 90 
2933 29 90 
2933 29 90 
2933 29 90 
2933 29 90 
2933 29 90 
2933 39 99 
2933 39 99 
2933 39 99 
2933 39 99 
2933 39 99 
2933 39 99 
2933 39 99 
2933 39 99 
2933 39 99 

2933 39 99 

Name 

CAS RN 
216167-92-9 camobucol  
211513-37-0 dalcetrapib  
69819-86-9 darinaparsin  
488832-69-5 elesclomol  
216167-95-2 elsibucol  
168682-53-9 ezatiostat  

58569-55-4 metenkefalin  

887148-69-8 monepantel  
603139-19-1 odanacatib  
162520-00-5 salirasib  
216167-82-7 succinobucol  
125961-82-2 tipelukast  
125973-56-0 amsilarotene  
253128-41-5 eribulin  
186953-56-0 pafuramidine  
195883-06-8 omtriptolide  
664338-39-0 arterolane  
183133-96-2 cabazitaxel  
401925-43-7 celivarone  
461432-26-8 dapagliflozin  
118457-15-1 dexnebivolol  
156294-36-9 larotaxel  
118457-16-2 levonebivolol  
83461-56-7 mifamurtide  

117570-53-3 vadimezan  
496775-61-2 eltrombopag  
206884-98-2 niraxostat  
410528-02-8 palovarotene  
376592-42-6 totrombopag  
183659-72-5 catramilast  
944263-65-4 demiditraz  
867153-61-5 dulanermin  
320367-13-3 lixisenatide  
698389-00-3 rolipoltide  
697766-75-9 velafermin  
147084-10-4 alcaftadine  

54-96-6 amifampridine  

249921-19-5 anamorelin  
319460-85-0 axitinib  
208110-64-9 befiradol  
330942-05-7 betrixaban  
201034-75-5 daporinad  
209783-80-2 entinostat  
412950-27-7 goxalapladib  

218791-21-0 imisopasem manganese  

EN 

7 

   EN 

 
Name 

CN code 

2933 39 99 
2933 39 99 
2933 39 99 
2933 39 99 
2933 39 99 
2933 39 99 
2933 39 99 
2933 39 99 
2933 39 99 
2933 39 99 
2933 39 99 
2933 39 99 
2933 39 99 

2933 49 90 

CAS RN 
103129-82-4 levamlodipine  
154357-42-3 levonadifloxacin  
108147-54-2 migalastat  
453562-69-1 motesanib  
139145-27-0 parogrelil  
459856-18-9 pexacerfont  
706779-91-1 pimavanserin  
362665-56-3 pitolisant 
861151-12-4 rosonabant  
701977-09-5 taranabant  
189950-11-6 tropantiol  
793655-64-8 vapitadine  
139290-65-6 volinaserin  

141388-76-3 besifloxacin  

2933 49 90 

697761-98-1 elvitegravir  

2933 49 90 

2933 49 90 

2933 49 90 

 2933 49 90 

2933 49 90 
2933 49 90 
2933 49 90 
2933 49 90 
2933 49 90 
2933 49 90 
2933 59 95 
2933 59 95 
2933 59 95 
2933 59 95 
2933 59 95 
2933 59 95 
2933 59 95 
2933 59 95 
2933 59 95 
2933 59 95 
2933 59 95 
2933 59 95 
2933 59 95 
2933 59 95 

185055-67-8 ferroquine  

445041-75-8 intiquinatine  

378746-64-6 nemonoxacin  

245765-41-7 ozenoxacin  

412950-08-4 rilapladib  

871224-64-5 almorexant  
863029-99-6 balamapimod  
698387-09-6 neratinib  
154652-83-2 tezampanel  
128253-31-6 veliflapon  
791828-58-5 aderbasib  
840486-93-3 adipiplon  
850649-61-5 alogliptin  
859212-16-1 bafetinib 
380843-75-4 bosutinib  
839712-12-8 cariprazine  
414910-27-3 casopitant  
288383-20-0 cediranib  
849550-05-6 cevipabulin  
827318-97-8 danusertib  
356057-34-6 darapladib  
501000-36-8 dutacatib  
247257-48-3 fimasartan  
3432-99-3 folitixorin  

EN 

8 

   EN 

 
 
 
 
 
Name 

CN code 

2933 59 95 
2933 59 95 
2933 59 95 
2933 59 95 
2933 59 95 
2933 59 95 
2933 59 95 
2933 59 95 
2933 59 95 
2933 59 95 
2933 59 95 
2933 59 95 
2933 69 80 
2933 79 00 
2933 79 00 
2933 79 00 
2933 79 00 
2933 79 00 
2933 79 00 
2933 79 00 
2933 79 00 
2933 79 00 
2933 79 00 
2933 79 00 
2933 79 00 
2933 79 00 
2933 79 00 
2933 99 80 
2933 99 80 
2933 99 80 
2933 99 80 
2933 99 80 
2933 99 80 
2933 99 80 
2933 99 80 
2933 99 80 
2933 99 80 
2933 99 80 
2933 99 80 
2933 99 80 
2933 99 80 
2933 99 80 
2933 99 80 
2933 99 80 
2933 99 80 
2933 99 80 

CAS RN 
668270-12-0 linagliptin  
441798-33-0 macitentan  
641571-10-0 nilotinib  
763113-22-0 olaparib  
686344-29-6 otenabant  
625115-55-1 riociguat  
486460-32-6 sitagliptin  
425637-18-9 sotrastaurin  
309913-83-5 talmapimod  
113857-87-7 talotrexin  
274693-27-5 ticagrelor  
306296-47-9 vicriviroc  
775351-65-0 imeglimin  
461443-59-4 aplaviroc  
189691-06-3 bremelanotide  
813452-18-5 carmegliptin  
405169-16-6 dovitinib  
536748-46-6 eribaxaban  
473289-62-2 ilepatril  
180694-97-7 mimopezil  
579475-18-6 orvepitant  
449811-01-2 pamapimod  
248282-01-1 paquinimod  
380917-97-5 perampanel  
552292-08-7 rolapitant  
425386-60-3 semagacestat  
515814-01-4 voclosporin  
481629-87-2 aleplasinin  
394730-60-0 boceprevir  
649735-63-7 brivanib alaninate  
483369-58-0 denagliptin  
284019-34-7 denibulin  
481631-45-2 diaplasinin  
272105-42-7 disitertide  
227318-71-0 epetirimod  
259793-96-9 favipiravir  
871576-03-3 flovagatran  
229305-39-9 golotimod  
258818-34-7 larazotide  
571170-77-9 laropiprant  
616202-92-7 lorcaserin  
868771-57-7 melogliptin  
803712-67-6 obatoclax  
404950-80-7 panobinostat  
625114-41-2 piragliatin  
74847-35-1 pyronaridine  

EN 

9 

   EN 

 
CN code 

2933 99 80 
2933 99 80 
2933 99 80 
2933 99 80 
2933 99 80 
2933 99 80 
2933 99 80 
2933 99 80 
2933 99 80 
2933 99 80 
2934 10 00 
2934 10 00 
2934 10 00 
2934 10 00 

2934 10 00 

2934 10 00 
2934 10 00 
2934 10 00 
2934 10 00 
2934 10 00 
2934 10 00 
2934 10 00 
2934 20 80 
2934 20 80 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 

2934 99 90 

2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 

2934 99 90 

2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 

Name 

CAS RN 
872178-65-9 rabeximod  
355151-12-1 rotigaptide  
497221-38-2 rusalatide  
187602-11-5 sofigatran  
227318-75-4 sotirimod  
402957-28-2 telaprevir  
848084-83-3 tigapotide  
393105-53-8 tiplasinin  
620948-93-8 vabicaserin  
794466-70-9 vernakalant  
544417-40-5 capadenoson 
302962-49-8 dasatinib  
223132-37-4 inolitazone  
241479-67-4 isavuconazole  

338990-84-4 isavuconazonium chloride 

607723-33-1 lobeglitazone  
280782-97-0 managlinat dialanetil  
790299-79-5 masitinib  
223673-61-8 mirabegron  
501948-05-6 rosabulin  
447406-78-2 sodelglitazar  
760937-92-6 teneligliptin  
848344-36-5 bentamapimod  
870093-23-5 talarozole  
320345-99-1 aclidinium bromide  
222551-17-9 adoprazine  
207623-20-9 agatolimod  
475479-34-6 aleglitazar  

870524-46-2 amolimogene bepiplasmid  

875446-37-0 anacetrapib  
250386-15-3 apadenoson  
541550-19-0 apilimod  
160707-69-7 apricitabine  
147403-03-0 azilsartan  
863031-21-4 azilsartan medoxomil  
757942-43-1 bederocin  

627861-07-8 beperminogene perplasmid  

959961-96-7 bevasiranib  
769901-96-4 capeserod  
868540-17-4 carfilzomib  
872847-66-0 cenersen  
80295-38-1 conestat alfa  
903916-27-8 custirsen  

EN 

10 

   EN 

 
CN code 

2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 

2934 99 90 

2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 

2934 99 90 

2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 
2934 99 90 

Name 

CAS RN 
187865-22-1 derquantel  
134379-77-4 dexelvucitabine  
247046-52-2 dilopetine  
480449-70-5 edoxaban  
188181-42-2 elacytarabine  
98819-76-2 esreboxetine  

763903-67-9 fosalvudine tidoxil  
172673-20-0 fosaprepitant  
522664-63-7 ibodutant  

405159-59-3 idrabiotaparinux sodium 

188116-07-6 imepitoin  
335619-18-6 inakalant  

1391-36-2 lancovutide  
189059-71-0 lapaquistat  
327026-93-7 lensiprazine  
170632-47-0 lificiguat  
852313-25-8 litenimod  
1000120-98-8 mipomersen  
62253-63-8 nepidermin  

26833-87-4 omacetaxine mepesuccinate 

269718-84-5 pardoprunox  
219923-85-0 pramiconazole  
377727-87-2 preladenant  
524684-52-4 prinaberel  
865311-47-3 quarfloxin  
869884-78-6 radezolid  
496054-87-6 radiprodil  
518048-05-0 raltegravir  
787548-03-2 regrelor  
820957-38-8 retosiban 
572924-54-0 ridaforolimus 
128517-07-7 romidepsin  
93265-81-7 ropidoxuridine  

151823-14-2 sapacitabine  
379231-04-6 saracatinib  
791635-59-1 simotaxel  
119567-79-2 taribavirin  
332012-40-5 telatinib  
925681-61-4 trabedersen  
189003-92-7 trelanserin  
296251-72-4 velimogene aliplasmid 
904302-98-3 viquidacin  
872525-61-6 votucalis  
221877-54-9 zotarolimus  

EN 

11 

   EN 

 
CN code 

2935 00 90 
2935 00 90 
2935 00 90 
2935 00 90 
2935 00 90 
2935 00 90 
2935 00 90 
2935 00 90 
2935 00 90 
2935 00 90 
2935 00 90 
2935 00 90 
2935 00 90 
2935 00 90 
2935 00 90 
2935 00 90 
2935 00 90 
2935 00 90 
2935 00 90 
2935 00 90 
2935 00 90 
2936 29 00 
2936 29 00 
2937 19 00 
2937 19 00 
2937 19 00 
2937 19 00 
2937 19 00 
2937 19 00 

2937 22 00 

2937 22 00 
2937 29 00 
2937 50 00 
2937 50 00 
2937 90 00 
2937 90 00  
2937 90 00 

2939 19 00 

2939 59 00 
2939 99 00 
2939 99 00 
2940 00 00 

2940 00 00 

Name 

CAS RN 
197904-84-0 apricoxib  
769169-27-9 begacestat  
414864-00-9 belinostat  
313682-08-5 brecanavir  
839673-52-8 cevoglitazar  
358970-97-5 drinabant  
865200-20-0 giripladib  
464213-10-3 ibipinabant  
173424-77-6 laromustine  
398507-55-6 lodenafil carbonate  
136564-68-6 masilukast  
170569-88-7 mavacoxib  
862189-95-5 mirodenafil  
439687-69-1 nelivaptan  
691852-58-1 nesbuvir  
778576-62-8 oglemilast  
444731-52-6 pazopanib  
362505-84-8 relacatib  
243984-11-4 resatorvid  
519055-62-0 tasisulam  
186497-07-4 zibotentan  
104121-92-8 eldecalcitol 

31690-09-2 levomefolic acid  

782500-75-8 albiglutide  
348119-84-6 obinepitide  
295350-45-7 ozarelix  
275371-94-3 taspoglutide  
218949-48-5 tesamorelin  
22006-64-0 tridecactide  

132245-57-9 dexamethasone cipecilate 

397864-44-7 fluticasone furoate 
211254-73-8 lonaprisan 
333963-42-1 cobiprostone  
172740-14-6 posaraprost  
834153-87-6 elagolix  
609799-22-6 tasimelteon  
342577-38-2 velneperit  

73232-52-7 methylnaltrexone bromide 

136199-02-5 rolofylline  
850607-58-8 darotropium bromide  
187852-63-7 delimotecan 

9007-72-1 ferric carboxymaltose 

442201-24-3 remogliflozin etabonate 

EN 

12 

   EN 

 
CN code 
2940 00 00  
2941 90 00 
2941 90 00 
2941 90 00 
2941 90 00 
2941 90 00  
2941 90 00 
2941 90 00 
2941 90 00 
2941 90 00 
2941 90 00 
2941 90 00  
2941 90 00 
3001 90 91 
3002 10 91 
3002 10 91 
3002 10 91 

3002 10 91 

Name 

CAS RN 
408504-26-7 sergliflozin etabonate 
467214-20-6 alvespimycin 
677017-23-1 berubicin 
229016-73-3 ceftaroline fosamil  
318498-76-9 flopristin  
145435-72-9 gamithromycin  
325965-23-9 linopristin  
857402-23-4 retaspimycin  
305841-29-6 sagopilone  

75747-14-7 tanespimycin 

328898-40-4 tildipirosin  
222400-20-6 tomopenem  
63409-12-1 tylvalosin  
9041-08-1 semuloparin sodium  

792921-10-9 abagovomab  
910649-32-0 anrukinzumab  
648904-28-3 bavituximab  
402710-27-4
 (light chain)
402710-25-2
 (heavy chain)

canakinumab  

3002 10 99 

945228-49-9 citatuzumab bogatox  

3002 10 91 
3002 10 91 
3002 10 91 
3002 10 91 
3002 10 91 
3002 10 91 
3002 10 91 
3002 10 91 
3002 10 91 
3002 10 91 
3002 10 91 

3002 10 91 

3002 10 91 
3002 10 91 
3002 10 91 
3002 10 91 
3002 10 91 
3002 10 91 
3002 10 91 

880486-59-9 dacetuzumab  
615258-40-7 denosumab  
762260-74-2 efungumab  
89957-37-9 gantenerumab  
680188-33-4 ibalizumab  
477202-00-9 ipilimumab  
640735-09-7 iratumumab  
845816-02-6 lexatumumab  
903512-50-5 lucatumumab  
899796-83-9 milatuzumab  
677010-34-3 motavizumab  

676258-98-3 naptumomab estafenatox 

828933-51-3 nimotuzumab  
949142-50-1 obinutuzumab 
637334-45-3 ocrelizumab  
881191-44-2 otelixizumab  
372075-37-1 sontuzumab  
705287-60-1 stamulumab  
339086-80-5 tadocizumab  

EN 

13 

   EN 

 
CN code 

3002 10 91 

3002 10 91 
3002 10 91 
3002 10 91 

3002 10 91 

3002 10 91 
3002 10 91  
3002 10 91  
3002 10 91  
3002 10 91  
3002 10 91  
3002 10 91  
3002 10 95 
3002 10 95 
3002 10 95 
3002 10 95 
3002 10 95 
3002 10 95 
3002 10 95 
3002 10 95 
3002 10 95 

3002 10 95 

3002 10 95  
3002 10 95  
3002 10 95  
3002 10 95  
3002 10 95  
3002 10 99 
3002 20 00 
3002 20 00 
3002 20 00 
3002 20 00 

3002 90 90 

3002 90 90 

3002 90 90 

3002 90 90 

3002 90 90 

3002 90 90 

CAS RN 
592557-43-2
 (light chain)
592557-41-0
 (heavy chain)

tenatumomab 

Name 

876387-05-2 teplizumab  
918127-53-4 tigatuzumab  
745013-59-6 tremelimumab 

339986-90-2 tucotuzumab celmoleukin  

728917-18-8 veltuzumab  
896731-82-1 conatumumab  
892553-42-3 etaracizumab  
944548-38-3 foravirumab  
944548-37-2 rafivirumab  
880266-57-9 tanezumab  
815610-63-0 ustekinumab  
862111-32-8 aflibercept  
845264-92-8 atacicept  
909110-25-4 baminercept  

9001-27-8 beroctocog alfa  

879555-13-2 epoetin kappa  
762263-14-9 epoetin theta  
501081-76-1 rilonacept  
267639-76-9 romiplostim  
869858-13-9 thrombin alfa  

897936-89-9 vatreptacog alfa (activated) 

472960-22-8 albinterferon alfa-2b  
869881-54-9 briobacept  
606138-08-3 catridecacog  
716840-32-3 denenicokin  
931101-84-7 troplasminogen alfa  
934216-54-3 alacizumab pegol  
181477-43-0 disomotide  
181477-91-8 ovemotide  
915019-08-8 tertomotide  
295371-00-5 verpasep caltespen 

473553-86-5 alferminogene tadenovec  

929881-05-0 alipogene tiparvovec  

600735-73-7 contusugene ladenovec 

851199-59-2 linaclotide 

898830-54-1 sitimagene ceradenovec 

721946-42-5 transferrin aldifitox 

EN 

14 

   EN 

 
CN code 

CAS RN 

Name 

3507 90 90 
3507 90 90 
3507 90 90 
3911 90 99 

9026-00-0 bucelipase alfa  

885051-90-1 pegloticase  
884604-91-5 velaglucerase alfa  
892497-01-7 azoximer bromide 

EN 

15 

   EN 

 
ANNEX II 

List of prefixes and suffixes which, in combination with the INNs of Annex 3 to Annex I 
to  Regulation  (EEC)  No  2658/87,  describe  the  salts,  esters  or  hydrates  of  INNs;  these 
salts, esters and hydrates are free of duty, on condition that they are classifiable in the 
same six-digit HS subheading as the corresponding INN 

The references to "International Nonproprietary Names (INN) for pharmaceutical substances, 
Names  for  radicals  &  groups,  comprehensive  list  2004"  are  replaced  by  "International 
Nonproprietary  Names  (INN)  for  pharmaceutical  substances,  Names  for  radicals,  groups  & 
others, comprehensive list 2007". 

The following prefixes or suffixes are added: 

Synonym 

Preferred prefix or 
suffix 

alanetil (INNRG)  

alaninate (INNRG) 
alapivoxil (INNRG) 

aldifitox (INNRG) 

besudotox (INNRG) 

ceribate (INNRG) 

cipecilate (INNRG) 

Systematic name when 
different 
[(S)-1-ethoxy-1-oxo-propan-
2-yl]amino (INNCN) 
L-alaninate (INNCN) 
L-alanyl, [(2,2-
dimethylpropanoyl)oxy]meth
yl (INNCN) 
(4-iminobutane-1,4-
diyl)sulfanediyl[(3RS)-2,5-
dioxopyrrolidine-1,3-diyl]-
1,3-phenylenecarbonyl and 
forming an N-benzoyl 
derivative of a primary amine 
group of diphtheria [550-L-
phenylalanine]toxin from 
Corynebacterium 
diphtheriae-(26-560)-peptide 
(INNCN) 
L-lysyl-L-alanyl-L-
serylglycylglycine (linker) 
fusion protein with des-(365-
380)-
[Asn364,Val407,Ser515,Gln590,G
ln606,Arg613]exotoxin A 
(Pseudomonas aeruginosa)-
(251-613)-peptide (toxin with 
region IA and first 16 
residues of region IB deleted) 
(INNCN) 
rac-2,3-dihydroxypropyl 
carbonate (ester) (INNCN) 
cyclohexanecarboxylate 
(ester), 
cyclopropanecarboxylate 
(ester) (INNCN) 

EN 

16 

   EN 

 
Synonym 

Preferred prefix or 
suffix 
dalanated (INNRG) 
enacarbil (INNRG) 

estafenatox (INNRG) 

etexilate (INNRG) 
fosamil (INNRG) 
glucuronide (INNRG)

medocaril (INNRG) 

paptox (INNRG) 

placarbil (INNRG) 

Systematic name when 
different 

des-B30-alanine (INNCN) 
{rac-1-[(2-
methylpropanoyl)oxy]ethoxy
}carbonyl (INNCN) 
glycylglycyl-L-proline 
(linker) fusion protein with 
enterotoxin type A 
(Staphylococcus aureus)-(1-
33)-peptidyl-L-
seryl[Ser36,Ser37,Glu38,Lys39,
Ala41,Thr46,Thr71,Ala72,Ser75,
Glu76,Glu78,Ser80,Ser81,Thr214,
Ser217,Thr219,Ser220,Ser222,Ser2
24]enterotoxin type E 
(Staphylococcus aureus)-(32-
230)-peptide (synthetic 
superantigen SEA/E-120) 
(INNCN) 
ethyl, (hexyloxy)carbonyl 
phosphono (INNCN) 
β-D-glucopyranosiduronic 
acid [oside] (INNCN) 
[(5-methyl-2-oxo-1,3-dioxol-
4-yl)methoxy]carbonyl 
(INNCN) 
protein PAP (Phytolacca 
americana antiviral) 
(INNCN) 
(R)-2-methyl-1-[(2-
methylpropanoyl)oxy]propox
y}carbonyl) (INNCN) 

The systematic name of the following prefix or suffix is amended as follows: 

Preferred prefix or 
suffix 

aritox (INNRG) 

Synonym 

Systematic name when 
different 

ricin A chain (INNCN) 

EN 

17 

   EN 

 
 
ANNEX III 

List  of  pharmaceutical  intermediates,  i.e.  compounds  used  for  the  manufacture  of 
finished pharmaceutical products, to be added to the list of products receiving duty-free 
treatment included in Annex 6 to Annex I to Regulation (EEC) No 2658/87 

ID  CN code 

CAS RN 

95 

2843 29 00 

22199-08-2 

428  2905 39 95 

281214-27-5 

2905 59 98 
76 
538  2909 30 90 

441002-17-1 
92878-95-0 

168  2909 30  

503070-57-3 

Name 
[4-amino-N-(pyrimidin-2(1H)-ylidene-
κN1)benzenesulfonamidato-κO]silver 
(2R,3R)-2,3-dimethylbutane-1,4-diyl bis(4-
methylbenzenesulfonate) 
4-chlorobutyl 2-nitrobenzenesulfonate 
2-(3-chloropropoxy)-1-methoxy-4-nitrobenzene 
2-({2-[(6-bromohexyl)oxy]ethoxy}methyl)-1,3-
dichlorobenzene 

386  2909 30  

461432-23-5 

4-(5-bromo-2-chlorobenzyl)phenyl ethyl ether 

51 
2909 49 80 
167  2909 49 80 

185954-75-0 
85309-91-7 

64 

2909 49 80 

160969-03-9 

98 
2909 50 00 
377  2910 20 00 
177  2910 90 00 

167145-13-3 
15448-47-2 
62600-71-9 

184  2910 90 00 

702687-42-1 

88 

2910 90 00 

683276-64-4 

191  2913 00 00 
2914 40 90 
38 

90035-34-0 
17752-16-8 

(3R)-3-methoxydecan-1-ol 
2-[(2,6-dichlorobenzyl)oxy]ethanol 
2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl 
methanesulfonate 
2-[2-(3-methoxyphenyl)ethyl]phenol 
(2R)-2-methyloxirane 
(2R)-2-(3-chlorophenyl)oxirane 
(2R)-2-[(5-bromo-2,3-
difluorophenoxy)methyl]oxirane 
[(2R)-2-methyloxiran-2-yl]methyl 4-
nitrobenzenesulfonate 
4'-(trifluoromethyl)biphenyl-4-carbaldehyde 
(3β)-3-hydroxycholest-5-en-24-one 

244  2914 50 00 

974-23-2 

(3β,16α)-3-hydroxy-16,17-epoxypregn-5-en-20-one 

586  2914 70 00 

13054-81-4 

4-chloro-heptane-3,5-dione 

236  2914 70 00 
122  2915 60 90 
426  2915 90 00 
266  2915 90 00 
2916 20 00 
19 
2916 20 00 
32 
37 
2916 20 00 
531  2916 39 00 
250  2916 39 00 

10226-30-9 
53064-79-2 
22328-90-1 
1069-66-5 
211515-46-7 
381209-09-2 
7077-05-6 
21900-39-0 
17625-03-5 

6-chlorohexan-2-one 
iodomethyl pivalate 
(3R)-3-methylhexanoic acid 
sodium 2-propylpentanoate 
1-(2-ethylbutyl)cyclohexanecarbonyl chloride 
1-(2-ethylbutyl)cyclohexanecarboxylic acid 
trans-4-(propan-2-yl)cyclohexanecarboxylic acid 
5-fluoro-2-methylbenzoyl chloride 
sodium hydrogen 3-sulfonatobenzoate 

561  2917 19 90 

76-72-2 

diethyl ethyl(pentan-2-yl)propanedioate 

193  2918 29 00 

376592-58-4 

5'-chloro-2'-hydroxy-3'-nitrobiphenyl-3-carboxylic 
acid 

EN 

18 

   EN 

 
ID  CN code 

CAS RN 

369  2918 99 90 

709031-28-7 

552  2918 99 90 
559  2918 99 90 

35480-52-5 
4651-67-6 

264  2918 99 90 

52179-28-9 

143  2918 99 90 

530141-60-7 

114  2920 90 10 

91526-18-0 

161  2921 49 00 

334477-60-0 

287  2921 49 00 

376608-71-8 

342  2921 49 00 

1034457-07-2 

27 
2921 49 00 
221  2921 49 00 

945717-05-5 
89-97-4 

26 

2921 49 00 

945717-43-1 

518  2921 51 90 

150812-21-8 

343  2922 19 80 

1035455-90-3 

397  2922 19 80 

0-00-0 

248  2922 19 80 

133-51-7 

344  2922 19 80 

1035455-87-8 

185  2922 19 80 

702686-97-3 

36 

2922 29 00 

20059-73-8 

536  2922 49 85 

848133-35-7 

425  2922 49 85 

610300-07-7 

424  2922 49 85 

610300-00-0 

433  2922 49 85 
398  2922 49 85 
475  2922 49 85 
174  2922 49 85 

143785-86-8 
848949-85-9 
39068-93-4 
168619-25-8 

Name 
(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)(oxo)acetic 
acid 
2,5-bis(2,2,2-trifluoroethoxy)benzoic acid 
(3α,5β)-3-hydroxy-7-oxocholan-24-oic acid 
ethyl 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-
methylpropanoate 
methyl 3-(5-{[4-(cyclopentyloxy)-2-
hydroxyphenyl]carbonyl}-2-
hydroxyphenyl)propanoate 
4-(hydroxymethyl)-5-methyl-1,3-dioxol-2-one 
(1R)-1-[3,5-bis(trifluoromethyl)phenyl]-N-
methylethanamine 
(1R,2S)-2-(3,4-difluorophenyl)cyclopropanaminium 
(2R)-hydroxy(phenyl)ethanoate 
2-(2,3-dihydro-1H-inden-2-yl)propan-2-amine 
hydrochloride 
2-(4-chloro-3-ethylphenyl)ethanamine hydrochloride 
2-chlorobenzylamine 
N-(4-tert-butylbenzyl)-2-(4-chloro-3-
ethylphenyl)ethanamine 
N4-[(4-fluorophenyl)methyl]-2-nitro-1,4-
benzenediamine 
(2R)-1-(5-bromo-2,3-difluorophenoxy)-3-{[1-(2,3-
dihydro-1H-inden-2-yl)-2-methylpropan-2- 
yl]amino}propan-2-ol hydrochloride 
[2-(chloromethyl)-4-
(dibenzylamino)phenyl]methanol hydrochloride 
antimonic acid -- 1-deoxy-1-(methylamino)-D-
glucitol (1:1) 
ethyl (2E)-3-(3-{[(2R)-3-{[1-(2,3-dihydro-1H-inden-
2-yl)-2-methylpropan-2-yl]amino}-2-
hydroxypropyl]oxy}-4,5-difluorophenyl)prop-2-
enoate hydrochloride 
ethyl 3-(3-{[(2R)-3-{[1-(2,3-dihydro-1H-inden-2-yl)-
2-methylpropan-2-yl]amino}-2-hydroxypropyl]oxy}-
4,5-difluorophenyl)propanoate hydrochloride 
2-[4-(aminomethyl)phenoxy]-N,N-
dimethylethanamine 
(2E)-4-(dimethylamino)but-2-enoic acid 
hydrochloride 
(3S,5R)-3-amino-5-methyloctanoic acid 
(3S,5R)-3-amino-5-methyloctanoic acid 
hydrochloride 
4-(1-aminocyclopropyl)-2,3,5-trifluorobenzoic acid 
4-fluoro-L-leucine -- ethyl hydrogen sulfate (1:1) 
methyl 2-(dimethylamino)-2-phenylbutanoate 
methyl 3'-aminobiphenyl-3-carboxylate 

EN 

19 

   EN 

 
ID  CN code 
565  2922 49 85 
474  2922 49 85 

CAS RN 
82834-12-6 
94133-84-3 

171  2922 50 00 

503070-58-4 

149  2924 19 00 
175  2924 19 00 

62009-47-6 
7355-58-0 

367  2924 29 98 

361442-00-4 

521  2924 29 98 

266993-72-0 

532  2924 29 98 

168080-49-7 

81 

2924 29 98 

317374-08-6 

125  2924 29 98 

143785-84-6 

434  2924 29 98 

143785-87-9 

80 

2924 29 98 

108166-22-9 

519  2924 29 98 

150812-23-0 

237  2924 29 98 

22316-45-6 

3 

2924 29 98 

316173-29-2 

378  2924 29 98 
102  2924 29 98 

1142-20-7 
84996-93-0 

270  2924 29 98 

579494-66-9 

533  2925 19 95 

265136-65-0 

33 

2926 90 95 

855425-38-6 

537  2926 90 95 

846023-24-3 

417  2926 90 95 
2926 90 95 
50 
2926 90 95 
54 
587  2926 90 95 

591769-05-0 
20099-89-2 
474554-45-5 
79370-78-8 

118  2926 90 95 

139481-28-0 

182  2928 00 90 

860035-10-5 

403  2928 00 90 

910656-45-0 

104  2928 00 90 

95759-10-7 

Name 
N-[(2S)-1-ethoxy-1-oxopentan-2-yl]-L-alanine 
sodium 2-amino-2-phenylbutanoate 
triphenylacetic acid -- 4-{(1R)-2-[(6-{2-[(2,6-
dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-
hydroxyethyl}-2-(hydroxymethyl)phenol (1:1) 
2-aminomalonamide 
N-(2-chloroethyl)acetamide 
{2-[(tert-butoxycarbonyl)amino]-3-
hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl}acetic acid 
2,3-diaminobenzamide dihydrochloride 
2-chloro-4-{[(5-fluoro-2-
methylphenyl)carbonyl]amino}benzoic acid 
2-methyl-4-{[(2-
methylphenyl)carbonyl]amino}benzoic acid 
4-(1-carbamoylcyclopropyl)-2,3,5-trifluorobenzoic 
acid 
4-[1-(acetylamino)cyclopropyl]-2,3,5-
trifluorobenzoic acid 
4-{[(2-methylphenyl)carbonyl]amino}benzoic acid 
ethyl {4-[(4-fluorobenzyl)amino]-2-
nitrophenyl}carbamate 
ethyl 3-[(5-chloro-2-nitrophenyl)(phenyl)amino]-3-
oxopropanoate 
methyl (1S,2S,3S,4R)-3-[(1S)-1-amino-2-
ethylbutyl]-4-[(tert-butoxycarbonyl)amino]-2-
hydroxycyclopentanecarboxylate 
N-benzyloxycarbonyl-L-alanine 
N-cyclohexyl-5-hydroxypentanamide 
propyl {4-[2-(diethylamino)-2-oxoethoxy]-3-
ethoxyphenyl}acetate 
ethyl 3-amino-4-[2-(1,3-dioxo-1,3-dihydro-2H-
isoindol-2-yl)ethoxy]but-2-enoate 
1-(2-ethylbutyl)cyclohexanecarbonitrile 
2-cyano-N-(2,4-dichloro-5-
methoxyphenyl)acetamide 
3-cyclopentylprop-2-enenitrile 
4-(bromoacetyl)benzonitrile 
4,5-diethoxy-3-fluorobenzene-1,2-dicarbonitrile 
5-hydroxybenzene-1,3-dicarbonitrile 
methyl 2-{[(2'-cyanobiphenyl-4-yl)methyl]amino}-3-
nitrobenzoate 
1-({[(2,5-dioxopyrrolidin-1-
yl)oxy]carbonyl}oxy)ethyl 2-methylpropanoate 
2-hydroxy-2-(trifluoromethyl)butanehydrazide 
4-chloro-2-[(2-methoxy-2-oxoethoxy)imino]-3-
oxobutanoic acid 

EN 

20 

   EN 

 
ID  CN code 

CAS RN 

383  2928 00 90 

473927-63-8 

144  2928 00 90 

158671-29-5 

106  2928 00 90 

84080-68-2 

105  2928 00 90 

268544-50-9 

101  2930 90 85 

13459-62-6 

20 

2930 90 85 

211513-21-2 

181  2930 90 85 

860035-07-0 

396  2930 90 85 

893407-18-6 

86 
2930 90 85 
180  2930 90 85 
2931 00 95 
47 

60759-00-4 
21048-05-5 
13682-94-5 

46 

2931 00 95 

914922-89-7 

44 

2931 00 95 

914922-88-6 

45 

2931 00 95 

871355-80-5 

192  2931 00 95 

89694-48-4 

359  2931 00 95 

701278-08-2 

360  2931 00 95 

701278-09-3 

318  2931 00 95 

796967-18-5 

52 
48 

2931 00 95 
2931 00 95 

172732-52-4 
185411-12-5 

43 

2932 19 00 

253128-10-8 

Name 
ethyl (2Z)-chloro[2-(4-
methoxyphenyl)hydrazinylidene]ethanoate 
N,2-dihydroxy-4-methylbenzamide 
tert-butyl (2Z)-2-[(2-methoxy-2-oxoethoxy)imino]-
3-oxobutanoate 
tert-butyl-2-[(2-methoxy-2-oxoethoxy)imino]-3-
oxobutanoate 
{2-[(4-chlorophenyl)sulfanyl]phenyl}acetic acid 
1-(2-ethylbutyl)-N-(2-
sulfanylphenyl)cyclohexanecarboxamide 
1-{[(methylsulfanyl)carbonyl]oxy}ethyl 2-
methylpropanoate 
2,2,2-trifluoro-1-[4'-(methylsulfonyl)biphenyl-4-
yl]ethanone 
3,4-diethoxybenzenecarbothioamide 
N-methylbenzenecarbothiohydrazide 
(2-bromoethenyl)(trimethyl)silane 
(2R,4R)-4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-
N-methoxy-N,2-dimethyl-7-oxoheptanamide 
(2R,4R)-4-{[tert-butyl(dimethyl)silyl]oxy}-N-
methoxy-N,2-dimethyloct-7-enamide 
(4R)-2-bromo-7-{[tert-
butyl(diphenyl)silyl]oxy}hept-1-en-4-yl 4-
methylbenzenesulfonate 
(5-chloro-2-methoxyphenyl)boronic acid 
[(1R,5S)-5-[dimethyl(phenyl)silyl]-2-{[(2-
methoxypropan-2-yl)oxy]methyl}cyclopent-2-en-1-
yl]methanol 
{(4S,5R)-5-[(benzyloxy)methyl]-4-
[dimethyl(phenyl)silyl]cyclopent-1-en-1-
yl}methanol 
1-(2-fluoro-5-methylphenyl)-3-[4-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea 
2-(1,3,2-dioxaborinan-2-yl)benzonitrile 
methyl 3-(trimethylsilyl)pent-4-enoate 
(1S)-1,5:7,10-dianhydro-12,13-bis-O-[tert-
butyl(dimethyl)silyl]-2,3,4,6,8,11-hexadeoxy-1-{2-
[(2S,5S)-5-(3-hydroxypropyl)-3-
methylidenetetrahydrofuran-2-yl]ethyl}-3-methyl-9-
O-methyl-4-methylidene-8-
[(phenylsulfonyl)methyl]-D-arabino-D-altro-
tridecitol 

EN 

21 

   EN 

 
ID  CN code 

CAS RN 

571  2932 19 00 

441045-17-6 

2932 29 85 
35 
554  2932 29 85 
140  2932 29 85 

916069-80-2 
63106-93-4 
7734-80-7 

399  2932 29 85 

0-00-0 

142  2932 29 85 

947408-91-5 

141  2932 29 85 

947408-90-4 

165  2932 99 00 

452342-08-4 

206  2932 99 00 

99541-23-8 

389  2932 99 00 

461432-25-7 

116  2932 99 00 

196597-79-2 

Name 
(1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S,26R,2
9S,31R,32S,33R,35R,36S)-20-[(2S)-3-amino-2-
hydroxypropyl]-21-methoxy-14-methyl-8,15-
bis(methylene)-2,19,30,34,37,39,40,41-
octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.01
8,22.029,36.031,35]hentetracontan-24-one 
methanesulfonate  
(4S)-4-(fluoromethyl)dihydrofuran-2(3H)-one 
1-phenyl-3-oxabicyclo[3.1.0]hexan-2-one 
2-oxo-2H-chromene-6-carboxylic acid 
4-(4-fluorophenyl)-7-(isothiocyanatomethyl)-2H-
chromen-2-one 
6-[(2,4-dihydroxyphenyl)carbonyl]-2H-chromen-2-
one 
6-[(2,4-dimethoxyphenyl)carbonyl]-2H-chromen-2-
one 
(1R)-2-(benzylamino)-1-(2,2-dimethyl-4H-1,3-
benzodioxin-6-yl)ethanol 
(1R,2S,3R,4R,5R)-4-azido-2-{[(4aR,6S,7R,8S,8aR)-
7,8-bis(benzyloxy)-2-phenylhexahydropyrano[3,2-
d][1,3]dioxin-6-yl]oxy}-6,8-dioxabicyclo[3.2.1]oct-
3-yl acetate 
(1S)-2,3,4,6-tetra-O-acetyl-1,5-anhydro-1-[4-chloro-
3-(4-ethoxybenzyl)phenyl]-D-glucitol 
(2E)-1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-
ylideneethanenitrile 

2932 99 00 

550 

3308-94-9 

2-(3-chloropropyl)-2-(4-fluorophenyl)-1,3-dioxolane 

568  2932 99 00 

274693-53-7 

61 

2932 99 00 

185954-98-7 

203  2932 99 00 

136172-58-2 

115  2932 99 00 

196597-80-5 

354  2932 99 00 

666860-59-9 

576  2932 99 00 

117661-72-0 

405  2932 99 00 

959624-24-9 

[(3aS,4R,6S,6aR)-6-hydroxy-2,2-
dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-
yl]carbamate 
[6(2Z,3R)]-3-O-decyl-2-deoxy-6-O-[2-deoxy-3-O-
(3-metoxydecyl)-6-methyl-2-[(1-oxo-11-
octadecenyl)amino]-4-O-phosphono-β-D-
glucopyranosyl]-2-[(1,3-dioxotetradecyl)amino]-α-
D-glucopyranose 1-(dihydrogen phosphate) 
tetrasodium salt 
1,6-di-O-acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-D-
glucopyranose 
2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-
yl]ethanamine hydrochloride 
2-amino-2-oxoethyl{3-[trans-5-(6-
methoxynaphthalen-1-yl)-1,3-dioxan-2-
yl]propyl}carbamate 
5-(chloromethyl)-6-methyl-1,3-benzodioxole 
6-(hydroxymethyl)-4-phenyl-3,4-dihydro-2H-
chromen-2-ol 

EN 

22 

   EN 

 
 
ID  CN code 

CAS RN 

388  2932 99 00 

960404-59-5 

13 

2932 99 00 

15826-37-6 

28 

2932 99 00 

204254-84-2 

205  2932 99 00 

99541-26-1 

204  2932 99 00 

114869-97-5 

478  2933 19 90 

1035677-60-1 

194  2933 19 90 

18048-64-1 

477  2933 19 90 

1035675-24-1 

310  2933 19 90 

1028026-83-6 

585  2933 19 90 

473921-12-9 

89 
90 

2933 29 90 
2933 29 90 

65902-59-2 
57531-37-0 

24 

2933 29 90 

1000164-35-1 

488  2933 29 90 

152074-97-0 

489  2933 29 90 

781666-30-6 

176  2933 29 90 

451470-33-0 

348  2933 39 99 

925978-49-0 

325  2933 39 99 

876170-44-4 

Name 
but-2-yne-1,4-diol -- methyl 1-C-[4-chloro-3-(4-
ethoxybenzyl)phenyl]-α-D-glucopyranoside (1:1) 
disodium 5,5'-[(2-hydroxypropane-1,3-
diyl)bis(oxy)]bis(4-oxo-4H-chromene-2-carboxylate) 
ethyl (3aR,7R,7aR)-2,2-dimethyl-7-
[(methylsulfonyl)oxy]-3a,6,7,7a-tetrahydro-1,3-
benzodioxole-5-carboxylate 
methyl (2S,3S,4S,5S,6S)-6-{[(1S,2S,3S,4R,5R)-3-
(acetyloxy)-4-azido-6,8-dioxabicyclo[3.2.1]oct-2-
yl]methyl}-4,5-bis(benzyloxy)-3-hydroxytetrahydro-
2H-pyran-2-carboxylate 
methyl 6-O-acetyl-4-O-(2-O-acetyl-3-O-benzyl-6-
methyl-α-L-idopyranuronosyl)-3-O-benzyl-2-
{[(benzyloxy)carbonyl]amino}-2-deoxy-α-D-
glucopyranoside 
(4S)-3-(4-chlorophenyl)-N-methyl-4-phenyl-4,5-
dihydro-1H-pyrazole-1-carboximidamide 2,3-
dihydroxybutanedioate 
2-(3,4-dimethylphenyl)-5-methyl-2,4-dihydro-3H-
pyrazol-3-one 
3-(4-chlorophenyl)-N-methyl-4-phenyl-4,5-dihydro-
1H-pyrazole-1-carboximidamide 
5-methyl-1-(propan-2-yl)-4-[4-(propan-2-
yloxy)benzyl]-1,2-dihydro-3H-pyrazol-3-one 
5-{[3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-
yl]oxy}benzene-1,3-dicarbonitrile 
2-bromo-4-nitro-1H-imidazole 
2-chloro-4-nitro-1H-imidazole 
3-(1,1-dimethylethyl)-N-[(9H-fluoren-9-
ylmethoxy)carbonyl]-1-(triphenylmethyl)-L-histidyl-
2-methylalanyl-L-α-glutamylglycine 
L-α-aspartyl-L-α-glutamyl-L-asparaginyl-L-prolyl-
L-valyl-L-valyl-L-histidyl-L-phenylalanyl-L-
phenylalanyl-L-lysyl-L-asparaginyl-L-isoleucyl-L-
valyl-L-threonyl-L-prolyl-L-arginyl-L-threonine 
L-α-aspartyl-L-α-glutamyl-L-asparaginyl-L-prolyl-
L-valyl-L-valyl-L-histidyl-L-phenylalanyl-L-
phenylalanyl-L-lysyl-L-asparaginyl-L-isoleucyl-L-
valyl-L-threonyl-L-prolyl-L-arginyl-L-threonine 
tetraacetate 
methyl 3'-(2-methyl-4,5-dihydro-1H-imidazol-1-
yl)biphenyl-3-carboxylate 
(+)-5-[6-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl]-1-
azabicyclo[3.2.1]octane 
(1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-
diazabicyclo[3.2.0]heptane benzenesulfonate 

EN 

23 

   EN 

 
ID  CN code 

CAS RN 

1 

2933 39 99 

741705-70-4 

Name 
(2R)-phenyl[(2R)-piperidin-2-yl]ethanoic acid 
hydrochloride 

162  2933 39 99 

414910-13-7 

(2S)-hydroxy(phenyl)ethanoic acid -- (2R)-2-(4-
fluoro-2-methylphenyl)piperidin-4-one (1:1) 

314  2933 39 99 

0-00-0 

315  2933 39 99 

370882-57-8 

121  2933 39 99 

334618-23-4 

579  2933 39 99 

1062580-52-2 

578  2933 39 99 

27262-47-1 

183  2933 39 99 

105812-81-5 

324  2933 39 99 

876068-51-8 

408  2933 39 99 

871022-14-9 

549  2933 39 99 

5421-92-1 

541  2933 39 99 

272776-12-2  

409  2933 39 99 

871022-19-4 

414  2933 39 99 

3613-73-8 

535  2933 39 99 
201  2933 39 99 

179687-79-7 
122321-04-4 

311  2933 39 99 

945405-37-8 

155  2933 39 99 

936637-40-0 

40 

2933 39 99 

88150-62-3 

404  2933 39 99 

84100-54-9 

157  2933 39 99 

873546-30-6 

158  2933 39 99 

873546-74-8 

(3aR,6aR)-1-(pyridin-3-yl)octahydropyrrolo[3,4-
b]pyrrole 4-methylbenzenesulfonate 
(3aR,6aR)-1-(pyridin-3-yl)octahydropyrrolo[3,4-
b]pyrrole dihydrochloride 
(3R)-piperidin-3-amine dihydrochloride 
(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine 
dihydrochloride 
(S)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-
carboxamide 
[(3S,4R)-4-(4-fluorophenyl)-1-methylpiperidin-3-
yl]methanol 
[(3S,4S)-4-amino-1-(5,6-dichloropyridin-3-
yl)pyrrolidin-3-yl]methanol 
1-({4-[({[2-oxo-3-(propan-2-yl)-2,3-dihydro-1H-
benzimidazol-1-
yl]carbonyl}amino)methyl]piperidin-1-
yl}methyl)cyclobutanecarboxylic acid 
1-(pyridin-4-yl)pyridinium chloride hydrochloride 
1,1'-binaphthalene-2,2'-diol -- 
5-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-
2-yl)methyl]sulfinyl}-1H-benzimidazole 
(1:1) 
1-[(4-{[(tert-
butoxycarbonyl)amino]methyl}piperidin-1-
yl)methyl]cyclobutanecarboxylic acid 
2,8-dimethyl-5-[2-(6-methylpyridin-3-yl)ethyl]-
2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole 
2-[(2-chloro-4-nitrophenoxy)methyl]pyridine 
2-[methyl(pyridin-2-yl)amino]ethanol 
2-methyl-3-[(2S)-pyrrolidin-2-ylmethoxy]pyridine 
2,3-dihydroxybutanedioate 
3,3'-piperidine-1,4-diyldipropan-1-ol 4-
methylbenzenesulfonate 
3-ethyl-5-methyl-4-(2-chlorophenyl)-2-{[2-(1,3-
dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]methyl}-
6-methyl-1,4-dihydropyridine-3,5-dicarboxylate 
4-(ethylamino)piperidine-4-carboxamide 
4,4'-[piperidine-1,4-diylbis(propane-3,1-
diyloxy)]bis(N'-hydroxybenzenecarboximidamide) 
4,4'-[piperidine-1,4-diylbis(propane-3,1-
diyloxy)]bis[N'-
(acetyloxy)benzenecarboximidamide] 

EN 

24 

   EN 

 
ID  CN code 

CAS RN 

159  2933 39 99 

873546-38-4 

156  2933 39 99 

873546-80-6 

316  2933 39 99 

78750-61-5 

87 

2933 39 99 

866109-93-5 

472  2933 39 99 

927889-51-8 

272  2933 39 99 

691882-47-0 

323  2933 39 99 
220  2933 39 99 
2933 39 99 
85 

876068-46-1 
1072-98-6 
298692-34-9 

349  2933 39 99 

550349-58-1 

160  2933 39 99 

414909-98-1 

164  2933 39 99 

56880-11-6 

273  2933 39 99 

548797-97-3 

352  2933 39 99 

0-00-0 

289  2933 39 99 

329003-65-8 

58 

2933 49 10 

417716-92-8 

584  2933 49 90 

503291-53-0 

539  2933 49 90 

103733-32-0 

581  2933 49 90 

503293-98-9 

583  2933 49 90 

503290-66-2 

Name 
4,4'-[piperidine-1,4-diylbis(propane-3,1-
diyloxy)]dibenzenecarboximidamide 
trihydrochloride pentahydrate 
4,4'-[piperidine-1,4-diylbis(propane-3,1-
diyloxy)]dibenzonitrile 
4-[(3-nitropyridin-2-yl)amino]phenol 
4-{4-[4-(trifluoromethoxy)phenoxy]piperidin-1-
yl}phenol 4-methylbenzenesulfonate 
4-bromo-2,6-diethylpyridine 4-
methylbenzenesulfonate 
4-hydroxybenzoic acid -- (2S,4E)-N-methyl-5-[5-
(propan-2-yloxy)pyridin-3-yl]pent-4-en-2-amine 
(1:1) 
5,6-dichloro-N-(2,2-dimethoxyethyl)pyridin-3-amine 
5-chloropyridin-2-amine  
6-(chloroacetyl)pyridine-2-carboxylic acid 
7-chloro-3-(6-methoxypyridin-3-yl)-N,N,5-
trimethyl-4-oxo-4,5-dihydro-3H-pyridazino[4,5-
b]indole-1-carboxamide 
benzyl 2-(4-fluoro-2-methylphenyl)-4-oxo-3,4-
dihydropyridine-1(2H)-carboxylate 
ethyl [(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-
yl)acetate 
N-(2-{[(2S)-3-{[1-(4-chlorobenzyl)piperidin-4-
yl]amino}-2-hydroxy-2-methylpropyl]oxy}-4-
hydroxyphenyl)acetamide 
N-[(S)-1-azabicyclo[2.2.2]oct-2-yl(phenyl)methyl]-
2,6-dichloro-3-(trifluoromethyl)benzamide 
hydrochloride 
sodium hydrogen [1-hydroxy-1-phosphono-2-
(pyridin-3-yl)ethyl]phosphonate hemipentahydrate 

4-{3-chloro-4-
[(cyclopropylcarbamoyl)amino]phenoxy}-7-
methoxyquinoline-6-carboxamide methanesulfonate 

2-ethylbutyl (3S,4aS,6S,8aR)-6-[3-chloro-2-(1H-
tetrazol-5-yl)phenoxy]decahydro-3-
isoquinolinecarboxylate 4-methylbenzenesulfonate 
 benzyl (3S)-6,7-dimethoxy-1,2,3,4-
tetrahydroisoquinoline-3-carboxylate hydrochloride 
(3S,4aS,6S,8aR)-6-hydroxy-2-
(methoxycarbonyl)decahydroisoquinoline-3-
carboxylic acid 
(3S,4aS,6S,8aR)-6-[3-chloro-2-(2H-tetrazol-5-
yl)phenoxy]decahydro-3-isoquinolinecarboxylic acid 
hydrochloride 

EN 

25 

   EN 

 
ID  CN code 

CAS RN 

580  2933 49 90 

134388-95-7 

328  2933 49 90 

868210-14-4 

545  2933 49 90 

00-00-0 

534  2933 49 90 

 848133-76-6 

479  2933 59 95 

869490-23-3 

421  2933 59 95 

941685-40-1 

416  2933 59 95 

941678-49-5 

420  2933 59 95 

941685-41-2 

394  2933 59 95 

957187-34-7 

190  2933 59 95 

356058-42-9 

395  2933 59 95 

0-00-0 

407  2933 59 95 
197  2933 59 95 

90213-66-4 
3934-20-1 

189  2933 59 95 

451487-18-6 

120  2933 59 95 

865758-96-9 

340  2933 59 95 

934815-71-1 

278  2933 59 95 

722543-31-9 

361  2933 59 95 

1032066-96-8 

Name 
(3S,4aS,8aR)-2-(methoxycarbonyl)-6-
oxodecahydroisoquinoline-3-carboxylic acid -- 
(1R)-1-phenylethanamine (1:1) 
4-(4-{[(2S,4R)-4-[acetyl(4-chlorophenyl)amino]-2-
methyl-3,4-dihydroquinolin-1(2H)-
yl]carbonyl}phenoxy)-2,2-dimethylbutanoic acid 
methyl 2-[(3R)-3-{3-[(E)-2-(7-chloroquinolin-2-
yl)ethenyl]phenyl}-3-({[1-
(hydroxymethyl)cyclopropyl]methyl}sulfanyl)propyl
]benzoate hydrochloride 
N-(4-chloro-3-cyano-7-ethoxyquinolin-6-
yl)acetamide 
(3,3-difluoropyrrolidin-1-yl){(2S,4S)-4-[4-
(pyrimidin-2-yl)piperazin-1-yl]pyrrolidin-2-
yl}methanone 
(3R)-3-cyclopentyl-3-[4-(7-{[2-
(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-
d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile 
(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-
d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile 
(3S)-3-cyclopentyl-3-[4-(7-{[2-
(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-
d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile 
[(8R)-8-(3,5-difluorophenyl)-10-oxo-6,9-
diazaspiro[4.5]dec-9-yl]acetic acid 
{2-[(4-fluorobenzyl)sulfanyl]-4-oxo-4,5,6,7-
tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl}acetic 
acid 
2,3-dihydroxy-2,3-bis(phenylcarbonyl)butanedioic 
acid -- ethyl [(8R)-8-(3,5-difluorophenyl)-10-oxo-
6,9-diazaspiro[4.5]dec-9-yl]acetate (1:1) 
2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine 
2,4-dichloropyrimidine 
2-[(4-fluorobenzyl)sulfanyl]-1,5,6,7-tetrahydro-4H-
cyclopenta[d]pyrimidin-4-one 
2-[(6-chloro-3-methyl-2,4-dioxo-3,4-
dihydropyrimidin-1(2H)-yl)methyl]benzonitrile 
2-[3-(6-{[2-(2,4-dichlorophenyl)ethyl]amino}-2-
methoxypyrimidin-4-yl)phenyl]-2-methylpropanoic 
acid phosphate 
2-{ethyl[3-({4-[(5-{2-[(3-fluorophenyl)amino]-2-
oxoethyl}-1H-pyrazol-3-yl)amino]quinazolin-7-
yl}oxy)propyl]amino}ethyl dihydrogen phosphate 
2-amino-9-{(1S,3R,4S)-3-[(benzyloxy)methyl]-4-
[dimethyl(phenyl)silyl]-2-methylidenecyclopentyl}-
1,9-dihydro-6H-purin-6-one -- methanesulfonate 
(2:1) 

EN 

26 

   EN 

 
ID  CN code 

CAS RN 

406  2933 59 95 

540737-29-9 

400  2933 59 95 

1137917-12-4 

422  2933 59 95 

941685-39-8 

419  2933 59 95 

941685-27-4 

365  2933 59 95 
567  2933 59 95 
423  2933 59 95 
215  2933 59 95 

1780-26-3 
145783-14-8 
3680-69-1 
61379-64-4 

219  2933 59 95 

55112-42-0 

338  2933 59 95 

0-00-0 

471  2933 59 95 

55293-96-4 

288  2933 59 95 

179688-01-8 

198  2933 59 95 

444731-74-2 

355  2933 59 95 

0-00-0 

484  2933 79 00 

586414-48-4 

486  2933 79 00 

425663-71-4 

34 

2933 79 00 

813452-14-1 

77 

2933 79 00 

5162-90-3 

384  2933 79 00 

536760-29-9 

78 
69 
72 
75 

2933 79 00 
2933 79 00 
2933 79 00 
2933 79 00 

4876-10-2 
5057-12-5 
54197-66-9 
22246-18-0 

Name 
3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-
d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-
oxopropanenitrile 2-hydroxypropane-1,2,3-
tricarboxylate 
3-{[6-(ethylsulfonyl)pyridin-3-yl]oxy}-5-{[(2S)-1-
hydroxypropan-2-yl]oxy}benzoic acid -- 1,4-
diazabicyclo[2.2.2]octane (2:1) 
3-cyclopentyl-3-[4-(7-{[2-
(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-
d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile 
4-(1H-pyrazol-4-yl)-7-{[2-
(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-
d]pyrimidine 
4,6-dichloro-2-methylpyrimidine 
4,6-dichloro-5-nitro-2-(propylsulfanyl)pyrimidine 
4-chloro-7H-pyrrolo[2,3-d]pyrimidine 
4-cyclopentylpiperazin-1-amine 
4-methylpiperazine-1-carbonyl chloride 
hydrochloride 
5-(benzylamino)-2-(3-methoxyphenyl)-7-(4-
methylpiperazin-1-yl)[1,2,4]triazolo[1,5-a]quinoline-
4-carbonitrile -- (2E)-but-2-enedioate (2:1) hydrate 
5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine-2-
carbaldehyde 
7-(benzyloxy)-6-methoxyquinazolin-4(3H)-one 
N-(2-chloropyrimidin-4-yl)-2,3-dimethyl-2H-
indazol-6-amine 
N-(5-fluoro-3-methyl-1H-indol-1-yl)-4-methyl-2-
(pyridin-2-yl)pyrimidine-5-carboxamide 
(-)-3-{3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-
methyl-2-oxopyridin-1(2H)-yl}-N,4-
dimethylbenzamide 
(1S)-1-amino-3-methyl-1,3,4,5-tetrahydro-2H-3-
benzazepin-2-one hydrochloride 
(4S)-1-[(2S,3S,11bS)-2-amino-9,10-dimethoxy-
1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-
a]isoquinolin-3-yl]-4-(fluoromethyl)pyrrolidin-2-one 
dihydrochloride 
3-(2-oxo-1,2-dihydroquinolin-4-yl)alanine 
3-chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-
2(1H)-one 
4-(bromomethyl)quinolin-2(1H)-one 
4,6,7,8-tetrahydroquinoline-2,5(1H,3H)-dione 
6-hydroxy-3,4-dihydroquinolin-2(1H)-one 
7-hydroxy-3,4-dihydroquinolin-2(1H)-one 

EN 

27 

   EN 

 
ID  CN code 

CAS RN 

380  2933 79 00 

536759-91-8 

382  2933 79 00 

503614-91-3 

485  2933 79 00 

586379-61-5 

368  2933 99 80 

709031-45-8 

376  2933 99 80 

649735-46-6 

276  2933 99 80 

51077-14-6 

277  2933 99 80 

631916-97-7 

564  2933 99 80 

80875-98-5 

313  2933 99 80 

948846-40-0 

302  2933 99 80 

1000164-36-2 

529  2933 99 80 
410  2933 99 80 
522  2933 99 80 

22162-51-2 
35681-40-4 
166170-15-6 

322  2933 99 80 

796967-16-3 

321  2933 99 80 

0-00-0 

196  2933 99 80 

444731-72-0 

415  2933 99 80 

19686-05-6 

524  2933 99 80 

912444-00-9 

Name 
ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-
4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-
carboxylate 
ethyl 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-
oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-
pyrazolo[3,4-c]pyridine-3-carboxylate 
methyl 3-(4-hydroxy-6-methyl-2-oxopyridin-1(2H)-
yl)-4-methylbenzoate 
(1S,3S,5S)-2-azabicyclo[3.1.0]hexane-3-
carboxamide methanesulfonate 
(2R)-1-({4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-
5-methylpyrrolo[2,1-f][1,2,4]triazin-6-
yl}oxy)propan-2-ol 
(2S)-1-(tert-butoxycarbonyl)azetidine-2-carboxylic 
acid 
(2S)-N-{4-[(Z)-
amino(methoxyimino)methyl]benzyl}-1-{(2R)-2-[3-
chloro-5-(difluoromethoxy)phenyl]-2-
hydroxyethanoyl}azetidine-2-carboxamide -- 
benzenesulphonic acid (1:1) 
(2S,3aS,7aS)-octahydro-1H-indole-2-carboxylic acid 
(2S,3S)-2,3-bis[(phenylcarbonyl)oxy]butanedioic 
acid -- ethyl (3aR,6aR)-hexahydropyrrolo[3,4-
b]pyrrole-5(1H)-carboxylate (1:1) 
(5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S)-
5-(3-amino-3-oxopropyl)-20-benzyl-23-[(2S)-butan-
2-yl]-14,38-bis{4-[(tert-
butoxycarbonyl)amino]butyl}-29-{[1-(tert-
butoxycarbonyl)-1H-indol-3-yl]methyl}-17-(3-tert-
butoxy-3-oxopropyl)-1-(1H-fluoren-9-yl)-
8,11,26,41,41-pentamethyl-32-(2-methylpropyl)-
3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaoxo-35-
(propan-2-yl)-2-oxa-
4,7,10,13,16,19,22,25,28,31,34,37,40-
tridecaazadotetracontan-42-oic acid 
1-(2-nitrobenzyl)-1H-pyrrole-2-carbaldehyde 
1-(propan-2-yl)-1,3-dihydro-2H-benzimidazol-2-one 
1-(tert-butoxycarbonyl)-2-methyl-D-proline 
1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-
5-methylphenyl)urea 
1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-
5-methylphenyl)urea hydrochloride 
2,3-dimethyl-2H-indazol-6-amine 
2,8-dimethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-
b]indole 
2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-
4-carboxamide 

EN 

28 

   EN 

 
ID  CN code 

CAS RN 

523  2933 99 80 

912445-36-4 

481  2933 99 80 

163457-23-6 

65 

2933 99 80 

239463-85-5 

150  2933 99 80 

55321-99-8 

375  2933 99 80 

952490-01-6 

274  2933 99 80 

942436-93-3 

275  2933 99 80 

942437-37-8 

285  2933 99 80 
582  2933 99 80 
2933 99 80 
71 

288385-88-6 
503293-47-8 
73963-42-5 

271  2933 99 80 

606143-52-6 

347  2933 99 80 

0-00-0 

373  2933 99 80 

872206-47-8 

151  2933 99 80 

259793-88-9 

562  2933 99 80 

1137606-74-6 

482  2933 99 80 

261953-36-0 

73 

2933 99 80 

80076-47-7 

188  2933 99 80 

52602-39-8 

235  2933 99 80 

145641-35-6 

540  2933 99 80 

87269-87-2 

21 

2933 99 80 

1012065-72-3 

563  2933 99 80 

131707-24-9 

124  2933 99 80 

105152-95-2 

117  2933 99 80 

139481-44-0 

393  2933 99 80 

0-00-0 

Name 
2-[(2S)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-
4-carboxamide dihydrochloride 
3,3-difluoropyrrolidine hydrochloride 
3-{5-[(2R)-2-aminopropyl]-7-cyano-2,3-dihydro-1H-
indol-1-yl}propyl benzoate (2R,3R)-2,3-
dihydroxybutanedioate 
3-oxo-3,4-dihydropyrazine-2-carboxamide 
4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-
methylpyrrolo[2,1-f][1,2,4]triazin-6-yl 2,2-
dimethylpropanoate 
4-amino-8-(2,5-dimethoxyphenyl)-N-
propylcinnoline-3-carboxamide 
4-amino-8-(2-fluoro-6-methoxyphenyl)-N-
propylcinnoline-3-carboxamide 
4-fluoro-2-methyl-1H-indol-5-ol 
5-(2-chloro-6-fluorophenyl)-2H-tetrazole 
5-(4-chlorobutyl)-1-cyclohexyl-1H-tetrazole 
5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-
hydroxyethoxy)-1-methyl-1H-benzimidazole-6-
carboxamide 
5-fluoro-1-(3-fluorobenzyl)-N-(1H-indol-5-yl)-1H-
indole-2-carboxamide 
5-methyl-4-oxo-1,4-dihydropyrrolo[2,1-
f][1,2,4]triazin-6-yl 2,2-dimethylpropanoate 
6-bromo-3-oxo-3,4-dihydropyrazine-2-carboxamide 
6-fluoro-3-oxo-3,4-dihydropyrazine-2-carbonitrile -- 
N-cyclohexylcyclohexanamine (1:1) 
6-iodo-1H-indazole 
8,9-difluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-
pyrido[3,2,1-ij]quinoline-2-carboxylic acid 
9H-carbazol-4-ol 
benzyl (2S,3aR,7aS)-octahydro-1H-indole-2-
carboxylate hydrochloride 
benzyl (2S,3aS,6aS)-octahydrocyclopenta[b]pyrrole-
2-carboxylate hydrochloride  
ethyl 2-amino-9,10-dimethoxy-1,6,7,11b-tetrahydro-
4H-pyrido[2,1-a]isoquinoline-3-carboxylate 
ethyl 6-bromo-5-hydroxy-1-methyl-2-
[(phenylsulfanyl)methyl]-1H-indole-3-carboxylate 
ethyl 7-(3-aminopyrrolidin-1-yl)-1-(2,4-
difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-
naphthyridine-3-carboxylate 
methyl 1-[(2'-cyanobiphenyl-4-yl)methyl]-2-ethoxy-
1H-benzimidazole-7-carboxylate 
methyl 1-tert-butyl-2-hydroxy-1H-pyrrolo[2,3-
b]pyridine-3-carboxylate 

EN 

29 

   EN 

 
ID  CN code 

CAS RN 

555  2933 99 80 

21688-11-9 

370  2933 99 80 

361440-67-7 

371  2933 99 80 

709031-38-9 

366  2933 99 80 

709031-43-6 

588  2933 49 90 

936359-25-0 

341  2934 10 00 

110130-88-6 

547  2934 10 00 

68672-66-2 

202  2934 10 00 

291536-35-1 

362  2934 10 00 

302964-24-5 

339  2934 10 00 

866920-24-3 

353  2934 10 00 

752253-39-7 

57 

2934 10 00 

914361-45-8 

363  2934 10 00 

302964-08-5 

107  2934 10 00 

127660-04-2 

135  2934 99 90 

17381-54-3 

60 

2934 99 90 

630100-90-2 

Name 
N2-[(benzyloxy)carbonyl]-L-glutaminyl-L-
asparaginyl-S-benzyl-L-cysteinyl-L-prolyl-L-
leucylglycinamide 
tert-butyl (1S,3S,5S)-3-carbamoyl-2-
azabicyclo[3.1.0]hexane-2-carboxylate 
tert-butyl (2S)-2-carbamoyl-2,3-dihydro-1H-pyrrole-
1-carboxylate 
tert-butyl [(1S)-2-[(1S,3S,5S)-3-cyano-2-
azabicyclo[3.1.0]hex-2-yl]-1-(3-
hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)-2-
oxoethyl]carbamate 
methyl 2-((R)-3-(3-((E)-2-(7-chloroquinolin-2-
yl)vinyl)phenyl)-3-(((1-
(hydroxymethyl)cyclopropyl)methyl)sulfanyl)propyl
)benzoate  
(2Z)-[(acetyloxy)imino](2-amino-1,3-thiazol-4-
yl)ethanoic acid 
(2Z)-{[(1-tert-butoxy-2-methyl-1-oxopropan-2-
yl)oxy]imino}[2-(tritylamino)-1,3-thiazol-4-
yl]ethanoic acid 
(5Z)-5-(4-fluorobenzylidene)-1,3-thiazolidine-2,4-
dione 
2-amino-N-(2-chloro-6-methylphenyl)-1,3-thiazole-
5-carboxamide 
3-[2-chloro-4-({4-methyl-2-[4-
(trifluoromethyl)phenyl]-1,3-thiazol-5-
yl}methoxy)phenyl]-1,2,4-oxadiazol-5(4H)-one 
4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-
cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-
methyl-N-(prop-2-yn-1-yl)-1,3-thiazol-2-amine 
L-lysine -- {[(2R,3R)-3-[4-(4-cyanophenyl)-1,3-
thiazol-2-yl]-2-(2,4-difluorophenyl)-1-(1H-1,2,4-
triazol-1- 
yl)butan-2-yl]oxy}methyl dihydrogen phosphate -- 
ethanol (1:1:1) 
N-(2-chloro-6-methylphenyl)-2-[(6-chloro-2-
methylpyrimidin-4-yl)amino]-1,3-thiazole-5-
carboxamide 
sodium (2Z)-(2-amino-1,3-thiazol-4-
yl)(hydroxyimino)ethanoate 
(1-benzothiophen-5-yl)acetic acid 
(1R)-1,2-anhydro-4-C-{(1E,3E)-4-
[(1S,2S,3E,5R,6R,9R)-5-(1-carboxylato-4-
cycloheptylpiperazin-2-yl)-6,9-dihydroxy-2,6-
dimethyl-11-oxooxacyclododec-3-en-1-yl]penta-1,3-
dien-1-yl}-3,5-dideoxy-1-[(2R,3S)-3-hydroxypentan-
2-yl]-D-erythropentitol 

EN 

30 

   EN 

 
ID  CN code 

CAS RN 

283  2934 99 90 

220099-91-2 

282  2934 99 90 

220100-81-2 

29 

2934 99 90 

161599-46-8 

30 

2934 99 90 

690270-65-6 

392  2934 99 90 

265121-04-8 

126  2934 99 90 

163680-80-6 

544  2934 99 90 

132335-46-7 

345  2934 99 90 

133413-70-4 

169  2934 99 90 

503068-36-8 

166  2934 99 90 

452339-73-0 

470  2934 99 90 

877130-28-4 

543  2934 99 90 

132335-44-5 

31 

2934 99 90 

812647-80-6 

551  2934 99 90 

00-00-0 

418  2934 99 90 

1029716-44-6 

Name 
(2R)-3'H-spiro[4-azabicyclo[2.2.2]octane-2,2'-
furo[2,3-b]pyridine] 
(2R)-3'H-spiro[4-azabicyclo[2.2.2]octane-2,2'-
furo[2,3-b]pyridine] (S,S)-2,3-
dihydroxybutanedioate 
(2R,3R,4R,5R)-2-(4-amino-5-fluoro-2-
oxopyrimidin-1(2H)-yl)-2-fluoro-5-
methyltetrahydrofuran-3,4-diyl diacetate 
(2R,3S,4R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-2-
azido-2-{[(2-
methylpropanoyl)oxy]methyl}tetrahydrofuran-3,4-
diyl bis(2-methylpropanoate) hydrochloride 
(3-{[(2R,3S)-2-{(1R)-1-[3,5-
bis(trifluoromethyl)phenyl]ethoxy}-3-(2-
fluorophenyl)morpholin-4-yl]methyl}-5-oxo-2,5-
dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid -- 1-
deoxy-1-(methylamino)-D-glucitol (1:2) 
(3S)-10-[1-(acetylamino)cyclopropyl]-9-fluoro-3-
methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-
ij]quinoline-6-carboxylic acid 
(3S)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-
(thiophen-2-yl)propan-1-amine 
(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-
4,10,12,16,22,24-hexamethyl-3,9,15,21-tetrakis(2-
methylpropyl)-1,7,13,19-tetraoxa-4,10,16,22-
tetraazacyclotetracosane-2,5,8,11,14,17,20,23-octone 
(5R)-3-(6-{2-[(2,6-
dichlorobenzyl)oxy]ethoxy}hexyl)-5-(2,2-dimethyl-
4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one 
(5R)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-
oxazolidin-2-one 
(6R)-6-cyclopentyl-6-[2-(2,6-diethylpyridin-4-
yl)ethyl]-3-[(5,7-dimethyl[1,2,4]triazolo[1,5-
a]pyrimidin-2-yl)methyl]-4-hydroxy-5,6-dihydro-
2H-pyran-2-one 
(S)-3-(dimethylamino)-1-(thiophen-2-yl)propan-1-ol  
{(2R,3S,4R,5R)-2-azido-5-(2,4-dioxo-3,4-
dihydropyrimidin-1(2H)-yl)-3,4-
bis[(phenylcarbonyl)oxy]tetrahydrofuran-2-
yl}methyl 3-chlorobenzoate 
1-(1-{4-[2-(4-fluorophenyl)-1,3-dioxolan-2-
yl]butyl}-1,2,3,6-tetrahydropyridin-4-yl)-1,3-
dihydro-2H-benzimidazol-2-one 
1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)-1H-pyrazole 

EN 

31 

   EN 

 
ID  CN code 

CAS RN 

358  2934 99 90 

165172-60-1 

139  2934 99 90 

519187-97-4 

49 

2934 99 90 

127000-90-2 

332  2934 99 90 

710281-33-7 

136  2934 99 90 

96803-30-4 

59 

2934 99 90 

913695-00-8 

286  2934 99 90 

376608-74-1 

55 

2934 99 90 

474554-48-8 

148  2934 99 90 

530141-72-1 

138  2934 99 90 

519188-55-7 

137  2934 99 90 

519188-42-2 

566  2934 99 90 

753015-42-8 

557  2934 99 90 

26638-53-9 

153  2934 99 90 

499785-81-8 

154  2934 99 90 

356782-84-8 

211  2934 99 90 

6504-57-0 

329  2934 99 90 

871484-32-1 

575  2934 99 90 

166964-09-6 

93 

2934 99 90 

655233-39-3 

542  2920 90 85  

89729-09-9 

Name 
1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-
yl]-5-methylpyrimidine-2,4(1H,3H)-dione -- 1-
methylpyrrolidin-2-one (1:1) 
1-[3-(2-benzo[b]thien-5-ylethoxy)propyl]-3-
azetidinol -- (2Z)-2-butenedioate (1:1) 
1-{[(2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiran-
2-yl]methyl}-1H-1,2,4-triazole 
2-({[(1R,3S)-3-{[2-(3-methoxyphenyl)-5-methyl-
1,3-oxazol-4-yl]methoxy}cyclohexyl]oxy}methyl)-
6-methylbenzoic acid 
2-(1-benzothiophen-5-yl)ethanol 
2-[({4-[(2,2-dimethyl-1,3-dioxan-5-yl)methoxy]-3,5-
dimethylpyridin-2-yl}methyl)sulfinyl]-
1Hbenzimidazole, sodium salt (1:1) 
2-{[(3aR,4S,6R,6aS)-6-{[5-amino-6-chloro-2-
(propylsulfanyl)pyrimidin-4-yl]amino}-2,2-
dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-
yl]oxy}ethanol 
2-bromo-1-[3-tert-butyl-4-methoxy-5-(morpholin-4-
yl)phenyl]ethanone 

3-(5-{[4-(cyclopentyloxy)-2-
hydroxyphenyl]carbonyl}-2-[(3-hydroxy-1,2-
benzoxazol-6-yl)methoxy]phenyl)propanoic acid 

3-[2-(1-benzothiophen-5-yl)ethoxy]-1-(3-
hydroxyazetidin-1-yl)propan-1-one 
3-[2-(1-benzothiophen-5-yl)ethoxy]propionic acid 
3-{(E)-2-[(3R)-pyrrolidin-3-yl]ethenyl}-5-
(tetrahydro-2H-pyran-4-yloxy)pyridine 
3-chloro-6-methyldibenzo[c,f][1,2]thiazepin-11(6H)-
one 5,5-dioxide 
3-oxo-4-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-3,4-
dihydropyrazine-2-carboxamide 
3-oxo-4-(β-D-ribofuranosyl)-3,4-dihydropyrazine-2-
carboxamide 

4-[3-hydroxy-3-phenyl-3-(thiophen-2-yl)propyl]-4-
methylmorpholin-4-ium methyl sulfate 

4-[4-({3-[(4-deoxy-4-fluoro-b-D-
glucopyranosyl)oxy]-5-(propan-2-yl)-1H-pyrazol-4-
yl}methyl)phenyl]-N-[1,3-dihydroxy-2-
(hydroxymethyl)propan-2-yl]butanamide 
4-chloro-3-methyl-1,2-oxazol-5-amine 
4-nitrobenzyl(6R,7R)-7-amino-8-oxo-3-[(2S)-
tetrahydrofuran-2-yl]-5-thia-1-azabicyclo[4.2.0]oct-
2-ene-2-carboxylate hydrochloride 
5,7-dioxa-6-thiaspiro[2.5]octane-6-oxide  

EN 

32 

   EN 

 
ID  CN code 

CAS RN 

172  2934 99 90 

388082-75-5 

134  2934 99 90 

4923-87-9 

Name 
5-[4-[[3-chloro-4-[(3-
fluorophenyl)methoxy]phenyl]amino]-6-
quinazolinyl]-2-furancarboxaldehyde -- 4-
methylbenzenesulfonate (1:1) 
5-bromo-1-benzothiophene 

146  2934 99 90 

947408-95-9 

6-(bromomethyl)-2-triphenylmethyl-1,2-
benzisoxazol-3(2H)-one 

145  2934 99 90 

947408-94-8 

110  2934 99 90 

67978-05-6 

357  2934 99 90 

1001859-46-6 

326  2934 99 90 

665058-78-6 

401  2934 99 90 

923591-06-4 

577  2934 99 90 

59337-92-7 

147  2934 99 90 

947409-01-0 

212  2934 99 90 

85006-31-1 

280  2934 99 90 

893428-72-3 

18 

2934 99 90 

390800-88-1 

99 

2934 99 90 

112913-94-7 

412  2934 99 90 

120788-03-6 

402  2935 00 90 

1198178-65-2 

556  2935 00 90 

39570-96-2 

6-methyl-2-trityl-1,2-benzoxazol-3(2H)-one 
diphenylmethyl(2R)-3-methyl-2-[(1R,5S)-3-(4-
methylphenyl)-7-oxo-4-oxa-2,6-
diazabicyclo[3.2.0]hept-2-en-6-yl]but-3-enoate 
DNA (synthetic plasmid vector pCOR human 
interferon beta signal peptide fusion protein with 21-
154-human acidic fibroblast growth factor-
specifying) 
DNA, d(T-sp-C-G-sp-T-sp-C-G-sp-T-sp-T-sp-T-sp-
T-sp-G-sp-A-sp-C-G-sp-T-sp-T-sp-T-sp-T-sp-Gsp- 
T-sp-C-G-sp-T-sp-T) 
methyl (5R,7S,10S)-10-tert-butyl-15,15-dimethyl-
3,9,12-trioxo-6,7,9,10,11,12,14,15,16,17,18,19-
dodecahydro-1H,5H-2,23:5,8-dimethano-
4,13,2,8,11-benzodioxatriazacyclohenicosine-7(3H)-
carboxylate 
methyl 3-(chlorosulfonyl)thiophene-2-carboxylate 
methyl 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-
2-[(2-triphenylmethyl-1,2-benzisoxazol-3(2H)-on- 
6-yl)methoxy]phenyl]propionate 
methyl 3-amino-4-methylthiophene-2-carboxylate 
N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-
piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-
yl)oxy]-4-quinazolinamine -- (2E)-2-butenedioate 
(1:2) 
N,N',N''-(boroxin-2,4,6-triyltris{[(1S)-3-
methylbutane-1,1-diyl]imino[(2S)-1-oxo-3-
phenylpropane-1,2-diyl]})tripyrazine-2-carboxamide 
N-{[4-(4-fluorobenzyl)morpholin-2-
yl]methyl}acetamide 
S-[(1R,3S)-1-oxidotetrahydrothiophen-3-yl] 
ethanethioate 
(1R,2R)-1-[(cyclopropylsulfonyl)carbamoyl]-2-
ethylcyclopropanaminium 4-methylbenzenesulfonate 
(2R)-3-(benzylsulfanyl)-N-[(2S)-1-{[(2S,3S)-1-
hydrazinyl-3-methyl-1-oxopentan-2-yl]amino}- 
3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-2-{[(4-
methylphenyl)sulfonyl]amino}propanamide 

EN 

33 

   EN 

 
ID  CN code 

CAS RN 

79 

2935 00 90 

24310-36-9 

346  2935 00 90 

0-00-0 

281  2935 00 90 

941690-55-7 

199  2935 00 90 

6973-09-7 

82 

2935 00 90 

193686-76-9 

130  2935 00 90 

123664-84-6 

133  2935 00 90 

149457-03-4 

132  2935 00 90 

149456-98-4 

319  2935 00 90 

141450-48-8 

391  2935 00 90 

289042-10-0 

187  2939 99 00 

7689-03-4 

239  2939 99 00 
173  2940 00 00 

477-29-2 
604-69-3 

333  2940 00 00 

647834-15-9 

127  2941 90 00 

76610-92-9 

570  3907 20 99 

913976-27-9 

Name 
1-[(4-methylphenyl)sulfonyl]-1,2,3,4-tetrahydro-5H-
1-benzazepin-5-one 
2-(cyclohexylmethyl)-N-{2-[(2S)-1-
methylpyrrolidin-2-yl]ethyl}-1,2,3,4-
tetrahydroisoquinoline-7-sulfonamide di[(2E)-but-2-
enedioate] hydrate 
3-[(methylsulfonyl)amino]-2-phenyl-N-[(1S)-1-
phenylpropyl]quinoline-4-carboxamide 
5-amino-2-methylbenzenesulfonamide 
7-chloro-1-[(4-methylphenyl)sulfonyl]-1,2,3,4-
tetrahydro-5H-1-benzazepin-5-one 
N-(5-methoxy-2-
phenoxyphenyl)methanesulfonamide 
N-[4-(N-formylglycyl)-5-hydroxy-2-
phenoxyphenyl]methanesulfonamide 
N-[4-(N-formylglycyl)-5-methoxy-2-
phenoxyphenyl]methanesulfonamide 
N-{2-[(4-hydroxyphenyl)amino]pyridin-3-yl}-4-
methoxybenzenesulfonamide hydrochloride 
N-{5-[(diphenylphosphoryl)methyl]-4-(4-
fluorophenyl)-6-(propan-2-yl)pyrimidin-2-yl}-N-
methylmethanesulfonamide 
(4S)-4-ethyl-4-hydroxy-1H-
pyrano[3',4':6,7]indolizino[1,2-b]quinoline-
3,14(4H,12H)-dione 
colchicoside 
1,2,3,4,6-penta-O-acetyl-β-D-glucopyranose 
2-(4-methoxybenzyl)thiophen-3-yl β-D-
glucopyranoside 
(6R,7R)-7-({N-[(4-ethyl-2,3-dioxopiperazin-1-
yl)carbonyl]-D-threonyl}amino)-3-{[(1-methyl-1H-
tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-
azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 
poly(oxy-1,2-ethanediyl), α-hydro-ω-methoxy, 
diester with 21N6, 21’N6-[[(N2, N6-dicarboxy-L-
lysyl-β-alanyl)imino]bis(1-oxo-2, 1-
ethanediyl)]bis[N-acetylglycyl-L-leucyl-L-tyrosyl-L-
alanyl-L-cysteinyl-L-histidyl-L-methionylglycyl-L-
prolyl-L-isoleucyl-L-threonyl-3-(1-naphthalenyl)-L-
alanyl-L-valyl-L-cysteinyl-L-glutaminyl-L-prolyl-L-
leucyl-L-arginyl-N-methylglycyl-L-lysinamide] 
cyclic (6→15), (6’→15’) bis(disulfide) 

EN 

34 

   EN 

 
 
ANNEX IV 

List  of  pharmaceutical  intermediates,  i.e.  compounds  used  for  the  manufacture  of 
finished  pharmaceutical  products,  to  be  withdrawn  from  the  list  of  products  receiving 
duty-free treatment included in Annex 6 to Annex I to Regulation (EEC) No 2658/87 due 
to their transfer to the list of products receiving duty-free treatment included in Annex 3 
to Annex I to Regulation (EEC) No 2658/87 

CN code 
2915 39 00  

CAS RN 

7753-60-8 

2937 29 00  

2920 90 85  163133-43-5 

2924 29 98  194085-75-1 

2933 39 99  103129-82-4 

2933 39 99  319460-85-0 

2934 10 00  302962-49-8 

2934 99 90  143491-57-0 

2934 99 90  98819-76-2 

2934 99 90  475479-34-6 

2934 99 90  377727-87-2 

17-alpha-hydroxy-3,20-dioxopregna-4,9(11)-diene-21-yl 
acetate 

Name 

see anecortave (INN) 
4-(nitrooxy)butyl (2S)-2-(6-methoxy-2-naphthyl)propanoate 

see naproxcinod (INN) 
2-(2-chlorophenyl)-2-hydroxyethyl carbamate 

see carisbamate (INN) 
3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-
chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-
dicarboxylate 

see levamlodipine (INN) 
N-methyl-2-{[3-((E)-2-pyridin-2-ylvinyl)-1H-indazol-6-
yl]sulfanyl}benzamide 

see axitinib (INN) 
N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-
hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-
yl}amino)thiazole-5-carboxamide 

see dasatinib (INN) 
(2R,5S)-4-amino-5-fluoro-1-[2-(hydroxymethyl)-1,3-
oxathiolan-5-yl]pyrimidin-2(1H)-one 

see emtricitabine(INN) 
(2S)-2-[(S)-(2-ethoxyphenoxy)phenylmethyl]morpholine 

see esreboxetine (INN) 
(2S)-2-methoxy-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-
yl)ethoxy]-1-benzothiophen-7-yl}propanoic acid 

see aleglitazar (INN) 
2-(2-furyl)-7-(2-{4-[4-(2-methoxyethoxy)phenyl]piperazin-1-
yl}ethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[2,3-c]pyrimidin-
5-amine 

2934 99 90  189003-92-7 

see preladenant (INN) 
2-{7-fluoro-2-oxo-4-[2-(4-thieno[3,2-c]pyridin-4-ylpiperazin-

EN 

35 

   EN 

 
 
 
 
 
 
 
 
 
 
 
 
 
CN code 

CAS RN 

Name 

1-yl)ethyl]quinolin-1(2H)-yl}acetamide 

2934 99 90  134379-77-4 

2934 99 90  518048-05-0 

2935 00 90  170569-88-7 

2935 00 90  186497-07-4 

see trelanserin (INN) 
4-amino-5-fluoro-1-[(2R,5S)-5-(hydroxymethyl)-2,5-
dihydrofuran-2-yl]pyrimidin-2(1H)-one 

see dexelvucitabine (INN) 
potassium 4-[N-(2-fluorobenzyl)carbamoyl]-1-methyl-2-[1-
methyl-1-(5-methyl-1,3,4-oxadiazole-2-carboxamido)ethyl]-
6-oxo-1,6-dihydropyrimidine-5-olate 

see raltegravir (INN) 
4-[5-(4-fluorophenyl)-3-(trifluoromethyl)pyrazol-1-
yl]benzene-1-sulfonamide 

see mavacoxib (INN) 
N-(3-methoxy-5-methylpyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2-
yl)phenyl]pyridine-3-sulfonamide 

see zibotentan (INN) 

EN 

36 

   EN